We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIIV icon
1976
i3 Verticals
IIIV
$325M
$360K ﹤0.01%
15,629
+2,157
+16% +$50.6K
MTUS icon
1977
Metallus
MTUS
$892M
$359K ﹤0.01%
25,381
+77
+0.3% +$1.16K
HIPO icon
1978
Hippo Holdings
HIPO
$869M
$359K ﹤0.01%
13,394
+1,573
+13% +$38.7K
EXAS
1979
DELISTED
Exact Sciences
EXAS
$358K ﹤0.01%
6,380
-95
-1% -$5.91K
PRTA icon
1980
Prothena Corp
PRTA
$466M
$358K ﹤0.01%
25,873
+536
+2% +$8.46K
CTO
1981
CTO Realty Growth
CTO
$823M
$358K ﹤0.01%
18,177
+6,284
+53% +$124K
BFST icon
1982
Business First Bancshares
BFST
$1.05B
$358K ﹤0.01%
13,918
-30
-0.2% -$806
FPI
1983
Farmland Partners
FPI
$425M
$355K ﹤0.01%
30,215
+5,580
+23% +$65.5K
HNST icon
1984
The Honest Company
HNST
$540M
$355K ﹤0.01%
51,223
+13,988
+38% +$79.2K
MCBS icon
1985
MetroCity Bankshares
MCBS
$1.05B
$352K ﹤0.01%
11,032
+1,012
+10% +$32.7K
CCRN
1986
DELISTED
Cross Country Healthcare
CCRN
$351K ﹤0.01%
19,322
VREX icon
1987
Varex Imaging
VREX
$780M
$351K ﹤0.01%
24,026
+1,890
+9% +$26.4K
RBCAA icon
1988
Republic Bancorp
RBCAA
$1.92B
$350K ﹤0.01%
5,008
+539
+12% +$38.5K
ARKO icon
1989
ARKO Corp
ARKO
$505M
$349K ﹤0.01%
53,033
SPRY icon
1990
ARS Pharmaceuticals
SPRY
$606M
$349K ﹤0.01%
33,086
+3,769
+13% +$52.8K
ENFN
1991
DELISTED
Enfusion, Inc.
ENFN
$348K ﹤0.01%
33,785
+4,993
+17% +$48.3K
WLFC icon
1992
Willis Lease Finance
WLFC
$1.15B
$347K ﹤0.01%
5,022
RYAM icon
1993
Rayonier Advanced Materials
RYAM
$570M
$347K ﹤0.01%
42,098
+5,660
+16% +$47.6K
THRY icon
1994
Thryv Holdings
THRY
$96.9M
$347K ﹤0.01%
23,422
+5,081
+28% +$80.1K
DFTX
1995
Definium Therapeutics
DFTX
$5.9B
$346K ﹤0.01%
49,662
+7,113
+17% +$48.9K
UFCS icon
1996
United Fire Group
UFCS
$1.38B
$345K ﹤0.01%
12,126
+90
+0.7% +$2.27K
EE icon
1997
Excelerate Energy
EE
$1.12B
$344K ﹤0.01%
11,381
PTLO icon
1998
Portillo's
PTLO
$365M
$344K ﹤0.01%
36,548
+4,674
+15% +$53.5K
PSFE icon
1999
Paysafe
PSFE
$405M
$343K ﹤0.01%
20,078
+1,990
+11% +$40.3K
NVRI icon
2000
Enviri
NVRI
$564M
$343K ﹤0.01%
44,580
+554
+1% +$4.63K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.